Researcher.Life Logo

Gut and Liver : Impact Factor & More

eISSN: 2005-1212pISSN: 1976-2283

Key Metrics

CiteScore
6.6
Eigenfactor
0.001 - 0.005
H-Index
54
Impact Factor
< 5
SJR
Q1Hepatology
SNIP
1.42
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Gut and Liver

Gut and Liver Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher EDITORIAL OFFICE GUT & LIVER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2007
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Gut and Liver ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Gut and Liver

Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization.
  • 7 May 2026
  • Gut and liver
Risk of Gastric Neoplasms in Patients with Autoimmune Gastritis: A Systematic Review and Meta-Analysis.
  • 6 May 2026
  • Gut and liver
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma.
  • 6 May 2026
  • Gut and liver
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?
  • 23 Apr 2026
  • Gut and liver
Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea.
  • 22 Apr 2026
  • Gut and liver
Comments on Creation of a Durable Conduit with a Novel Self-Expandable Metal Stent for Stone Extraction in Endoscopic Retrograde Cholangiopancreatography: A Pilot Study.
  • 13 Apr 2026
  • Gut and liver
Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization.
  • 7 May 2026
  • Gut and liver
Risk of Gastric Neoplasms in Patients with Autoimmune Gastritis: A Systematic Review and Meta-Analysis.
  • 6 May 2026
  • Gut and liver
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma.
  • 6 May 2026
  • Gut and liver
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?
  • 23 Apr 2026
  • Gut and liver
Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea.
  • 22 Apr 2026
  • Gut and liver
Comments on Creation of a Durable Conduit with a Novel Self-Expandable Metal Stent for Stone Extraction in Endoscopic Retrograde Cholangiopancreatography: A Pilot Study.
  • 13 Apr 2026
  • Gut and liver

FAQs on Gut and Liver